NEUP
NASDAQ · Biotechnology
Neuphoria Therapeutics Inc
$3.63
-0.02 (-0.55%)
Open$3.65
Previous Close$3.65
Day High$3.66
Day Low$3.61
52W High$21.40
52W Low$3.19
Volume—
Avg Volume16.3K
Market Cap19.75M
P/E Ratio—
EPS$-5.00
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+307.4% upside
Current
$3.63
$3.63
Target
$14.79
$14.79
$9.77
$14.79 avg
$16.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.44M | 5.17M | 4.87M |
| Net Income | -16,469,521 | -354,866 | -256,361 |
| Profit Margin | -1,145.7% | -6.9% | -5.3% |
| EBITDA | -19,329,433 | -507,265 | -425,609 |
| Free Cash Flow | — | -183,163 | -132,058 |
| Rev Growth | — | -7.1% | +6.1% |
| Debt/Equity | 0.00 | 0.39 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |